{"d":{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Subject(ID=71799L,Language='FR')","uri":"https://ws.parlament.ch/OData.svc/Subject(ID=71799L,Language='FR')","type":"itsystems.Pd.DataServices.DataModel.Subject"},"Meetings":{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Meeting(ID=5242L,Language='FR')","uri":"https://ws.parlament.ch/OData.svc/Meeting(ID=5242L,Language='FR')","type":"itsystems.Pd.DataServices.DataModel.Meeting"},"Sessions":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Meeting(ID=5242L,Language='FR')/Sessions"}},"Subjects":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Meeting(ID=5242L,Language='FR')/Subjects"}},"ID":"5242","Language":"FR","MeetingNumber":10,"IdSession":5214,"SessionNumber":14,"SessionName":"Session d'\u00e9t\u00e9 2026","Council":1,"CouncilName":"Conseil national","CouncilAbbreviation":"CN","Date":"\/Date(1781481600000)\/","Begin":"1430","Modified":"\/Date(1784644716883)\/","LegislativePeriodNumber":52,"PublicationStatus":"final","MeetingOrderText":"Dixi\u00e8me s\u00e9ance","SortOrder":10,"Location":"N"},"SubjectsBusiness":{"results":[{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20267489,IdSubject=71799L,Language='FR')","uri":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20267489,IdSubject=71799L,Language='FR')","type":"itsystems.Pd.DataServices.DataModel.SubjectBusiness"},"Subjects":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20267489,IdSubject=71799L,Language='FR')/Subjects"}},"Businesses":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20267489,IdSubject=71799L,Language='FR')/Businesses"}},"IdSubject":"71799","BusinessNumber":20267489,"Language":"FR","BusinessShortNumber":"26.7489","Title":"Parcours des particules d\u2019ARNm dans le corps humain","SortOrder":1,"PublishedNotes":null,"Modified":"\/Date(1781264378563)\/","TitleDE":"Fragestunde.\nFrage Vontobel Erich.\nVerhalten von mRNA-Partikeln\nim menschlichen K\u00f6rper","TitleFR":"Heure des questions.\nQuestion Vontobel Erich.\nParcours des particules d'ARNm\ndans le corps humain","TitleIT":null}]},"Transcripts":{"results":[{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Transcript(ID=376749L,Language='FR')","uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=376749L,Language='FR')","type":"itsystems.Pd.DataServices.DataModel.Transcript"},"Subjects":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=376749L,Language='FR')/Subjects"}},"MembersCouncil":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=376749L,Language='FR')/MembersCouncil"}},"Businesses":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=376749L,Language='FR')/Businesses"}},"ID":"376749","Language":"FR","IdSubject":"71799","VoteId":null,"PersonNumber":4238,"Type":1,"Text":"<pd_text><p>Sogenannte dendritische Zellen in Haut und Muskulatur nehmen den Impfstoff auf und wandern zu den lokalen Lymphknoten. Aufgrund der Lipidh\u00fclle wird der Impfstoff von den Zellen an der Einstichstelle gut aufgenommen. Dieses Prozedere der Impfung ist klassisch und entspricht dem generellen physiologischen Ablauf von Impfungen. Der Corona-Impfstoff unterscheidet sich diesbez\u00fcglich nicht von klassischen Impfstoffen. Die mRNA ist instabil und wird rasch abgebaut.</p>\n<p>Spezifische Biodistributionsstudien von mRNA-Impfstoffen beim Menschen bleiben Gegenstand der internationalen Forschung. Die zugrunde liegenden immunologischen Prozesse untersucht man in der Schweiz in verschiedenen Forschungsprogrammen, insbesondere in universit\u00e4ren Kohortenstudien zur Impfantwort, etwa in der ZVAC-Studie der Universit\u00e4t Z\u00fcrich. Die Ergebnisse sind \u00fcber wissenschaftliche Publikationen sowie die jeweiligen Studienplattformen der Universit\u00e4ten bzw. Hochschulen \u00f6ffentlich zug\u00e4nglich.</p>\n</pd_text>","MeetingCouncilAbbreviation":"N","MeetingDate":"20260615","MeetingVerbalixOid":4185,"IdSession":"5214","SpeakerFirstName":"Elisabeth","SpeakerLastName":"Baume-Schneider","SpeakerFullName":"Baume-Schneider Elisabeth","SpeakerFunction":"BR-F","CouncilId":99,"CouncilName":"Conseil f\u00e9d\u00e9ral","CantonId":26,"CantonName":"Jura","CantonAbbreviation":"JU","ParlGroupName":null,"ParlGroupAbbreviation":null,"SortOrder":1,"Start":"\/Date(1781534967553)\/","End":"\/Date(1781535051490)\/","Function":"BR-F","DisplaySpeaker":true,"LanguageOfText":"DE","Modified":"\/Date(1785314634072)\/","StartTimeWithTimezone":"\/Date(1781534967553+0120)\/","EndTimeWithTimezone":"\/Date(1781535051490+0120)\/","VoteBusinessNumber":null,"VoteBusinessShortNumber":null,"VoteBusinessTitle":null}]},"ID":"71799","Language":"FR","IdMeeting":"5242","VerbalixOid":804576,"SortOrder":11,"Modified":"\/Date(1785314634068)\/"}}